Plain-English translation of NCT05093231 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether combining two medications — and — can help treat advanced pancreatic cancer that has spread to other parts of the body. These medications work in different ways to fight cancer cells, and researchers want to see if using them together is more effective. This approach targets pancreatic cancers with specific genetic features that make them more likely to respond to this combination.
Advanced pancreatic cancer is very difficult to treat, and current standard treatments don't work well for everyone. Researchers believe that targeting cancers with specific genetic mutations using this medication combination might offer new hope for patients who haven't benefited from other treatments.
You likely qualify if…
You likely don't qualify if…
You would receive as an intravenous infusion (injection into a vein) every three weeks, and take as pills by mouth twice daily throughout each three-week cycle. The trial expects to enroll about 20 participants and will monitor your response to treatment and any side effects you experience. Your participation would involve regular clinic visits, blood tests, and imaging scans to see how well the treatment is working.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Australia
United Kingdom